Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * White Timothy Ogden 2. Issuer Name and Ticker or Trading Symbol Alamar Biosciences, Inc. [ALMR] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President (Last) (First) (Middle) C/O ALAMAR BIOSCIENCES, INC., 47071 BAYSIDE PARKWAY 3. Date of Earliest Transaction (Month/Day/Year) 04/16/2026 (Street) FREMONT, CA 94538 4. If Amendment, Date Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class B Common Stock 04/20/2026 J(1) 454,583 D (1) 0 D Common Stock 04/20/2026 J(1) 454,583 A (1) 454,583 D Common Stock 04/20/2026 A(2) 37,220 A $ 0 491,803 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$17	04/16/2026		A		163,358		(3)	04/15/2036	Common Stock	163,358	$ 0	163,358	D
Stock Option (Right to Buy)	$0.59	04/20/2026		J(1)			29,357	(4)	04/20/2031	Class B Common Stock	29,357	$ 0	0	D
Stock Option (Right to Buy)	$0.59	04/20/2026		J(1)		29,357		(4)	04/20/2031	Common Stock	29,357	$ 0	29,357	D
Stock Option (Right to Buy)	$2.28	04/20/2026		J(1)			8,726	(4)	02/15/2032	Class B Common Stock	8,726	$ 0	0	D
Stock Option (Right to Buy)	$2.28	04/20/2026		J(1)		8,726		(4)	02/15/2032	Common Stock	8,726	$ 0	8,726	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(1)			10,686	(5)	04/16/2034	Class B Common Stock	10,686	$ 0	0	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(1)		10,686		(5)	04/16/2034	Common Stock	10,686	$ 0	10,686	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(1)			206,782	(6)	01/15/2035	Class B Common Stock	206,782	$ 0	0	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(1)		206,782		(6)	01/15/2035	Common Stock	206,782	$ 0	206,782	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(1)			8,532	(7)	01/15/2035	Class B Common Stock	8,532	$ 0	0	D
Stock Option (Right to Buy)	$3.34	04/20/2026		J(1)		8,532		(7)	01/15/2035	Common Stock	8,532	$ 0	8,532	D
Stock Option (Right to Buy)	$3.1	04/20/2026		J(1)			5,775	(8)	04/08/2035	Class B Common Stock	5,775	$ 0	0	D
Stock Option (Right to Buy)	$3.1	04/20/2026		J(1)		5,775		(8)	04/08/2035	Common Stock	5,775	$ 0	5,775	D
Stock Option (Right to Buy)	$7.6	04/20/2026		J(1)			16,333	(9)	01/14/2036	Class B Common Stock	16,333	$ 0	0	D
Stock Option (Right to Buy)	$7.6	04/20/2026		J(1)		16,333		(9)	01/14/2036	Common Stock	16,333	$ 0	16,333	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
White Timothy Ogden C/O ALAMAR BIOSCIENCES, INC. 47071 BAYSIDE PARKWAY FREMONT, CA 94538			President

Signatures

/s/ Timothy White		04/20/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock.
(2)	Represents the grant of restricted stock units ("RSUs"). The RSUs vest monthly from the date of grant, subject to the reporting person's continuous service as of each such vesting date.
(3)	Twenty-five percent of the shares subject to the option vest on April 16, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
(4)	Fully vested.
(5)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2024, subject to the reporting person's continuous service as of each such vesting date.
(6)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 16, 2025, subject to the reporting person's continuous service as of each such vesting date.
(7)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
(8)	Twenty-five percent of the shares subject to the option vest on January 1, 2026, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service as of each such vesting date.
(9)	The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2026, subject to the reporting person's continuous service as of each such vesting date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.